Williams-Sonoma, Uber And 2 Other Stocks Insiders Are Selling

The Nasdaq 100 closed higher by 0.1% on Thursday. Investors, meanwhile, focused on some notable insider trades.

When insiders sell shares, it could be a preplanned sale, or could indicate their concern in the company’s prospects or that they view the stock as being overpriced. Insider sales should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a selling decision.

Below is a look at a few recent notable insider sales. For more, check out Benzinga's insider transactions platform.

Williams-Sonoma

• The Trade: Williams-Sonoma, Inc. WSM President and CEO Laura Alber sold a total of 18,189 shares at an average price of $154.92. The insider received around $2.82 million from selling those shares.
• What’s Happening: Williams-Sonoma reported better-than-expected third-quarter adjusted earnings.
• What Williams-Sonoma Does: With a wide retail and direct-to-consumer presence, Williams-Sonoma is a leader in the $300 billion domestic home category, focused on expanding its exposure in the B2B, marketplace, and franchise areas.

Have a look at our premarket coverage here

Uber Technologies

• The Trade: Uber Technologies, Inc. UBER CEO Dara Khosrowshahi sold a total of 100,000 shares at an average price of $52.84. The insider received around $5.28 million from selling those shares. Jill Hazelbaker also sold 18,850 shares of the company.
• What’s Happening: Uber reported third-quarter FY23 revenue growth of 11% year-on-year to $9.29 billion, missing the consensus of $9.52 billion.
• What Uber Technologies Does: Uber Technologies is a technology provider that matches riders with drivers, hungry people with restaurants and food delivery service providers, and shippers with carriers.

Vertex Pharmaceuticals

• The Trade: Vertex Pharmaceuticals Incorporated VRTX EVP and CMO Carmen Bozic sold a total of 5,650 shares at an average price of $380.82. The insider received around $2.15 million from selling those shares.
• What’s Happening: Crispr and Vertex Pharmaceuticals announced that the United Kingdom Medicines and Healthcare products Regulatory Agency (MHRA) granted the companies conditional marketing authorization for CASGEVY, a CRISPR/Cas9 gene-edited therapy for the treatment of sickle cell disease.
• What Vertex Pharmaceuticals Does: Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases.

Seagate Technology

• The Trade: Seagate Technology Holdings plc STX EVP & Chief Commercial Officer Ban Seng sold a total of 5,000 shares at an average price of $75.00. The insider received around $375,025 from selling those shares.
• What’s Happening: Seagate reported first-quarter revenues of $1.454 billion, missing the analyst consensus of $1.530 billion. Revenues slumped 28.6% Y/Y.
• What Seagate Does: Seagate is a leading supplier of hard disk drives for data storage to the enterprise and consumer markets.

Check This Out: Jim Cramer Says 'This Is Not The Time To Sell' This Online Gaming Platform Stock